In vivo sensitivity of human melanoma to tumor necrosis factor (TNF)-alpha is determined by tumor production of the novel cytokine endothelial-monocyte activating polypeptide II (EMAPII).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples